Terms: = Lung cancer AND TRD
15 results:
1. A randomized sham-controlled trial of high-dosage accelerated intermittent theta burst rTMS in major depression: study protocol.
Goodman MS; Vila-Rodriguez F; Barwick M; Burke MJ; Downar J; Hunter J; Kaster TS; Knyahnytska Y; Kurdyak P; Maunder R; Thorpe K; Trevizol AP; Voineskos D; Zhang W; Blumberger DM
BMC Psychiatry; 2024 Jan; 24(1):28. PubMed ID: 38191370
[TBL] [Abstract] [Full Text] [Related]
2. Identification and characterization of the T cell receptor (TCR) repertoire of the cynomolgus macaque (Macaca Fascicularis).
Jaiswal S; Nyquist SK; Boyce S; Jivanjee T; Ibrahim S; Bromley JD; Gatter GJ; Gideon H; Patel K; Ganchua SK; Berger B; Fortune SM; Flynn JL; Shalek AK; Behar SM
BMC Genomics; 2022 Sep; 23(1):647. PubMed ID: 36096729
[TBL] [Abstract] [Full Text] [Related]
3. Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Minegishi Y; Akagami T; Arai M; Saito R; Arai D; Murase K; Miura K; Watanabe S; Sakashita H; Miyabayashi T; Honda R; Jingu D; Hotta T; Isobe K; Nakazawa K; Ito K; Takamura K; Inomata M; Harada T; Sakakibara R; Nakagawa T; Shibuya H; Takenaka K; Kobayashi K; Seike M
Lung Cancer; 2022 Oct; 172():1-8. PubMed ID: 35952438
[TBL] [Abstract] [Full Text] [Related]
4. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
[TBL] [Abstract] [Full Text] [Related]
5. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior.
Sahin IH; Elias H; Chou JF; Capanu M; O'Reilly EM
BMC Cancer; 2018 Jul; 18(1):769. PubMed ID: 30055578
[TBL] [Abstract] [Full Text] [Related]
6. Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell lung cancer: A Meta-Analysis of Randomized Studies.
Zhao J; Xia Y; Kaminski J; Hao Z; Mott F; Campbell J; Sadek R; Kong FM
PLoS One; 2016; 11(6):e0157455. PubMed ID: 27300551
[TBL] [Abstract] [Full Text] [Related]
7. Risk of treatment related death and febrile neutropaenia with first line palliative chemotherapy for de novo metastatic breast cancer in clinical practice in a middle resource country.
Phua CE; Tang WH; Yusof MM; Saad M; Alip A; See MH; Taib NA
Asian Pac J Cancer Prev; 2014; 15(23):10263-6. PubMed ID: 25556458
[TBL] [Abstract] [Full Text] [Related]
8. Primary γδ T cell lymphoma of the lung: report of a case with features suggesting derivation from intraepithelial γδ T lymphocytes.
Choe JY; Bisig B; de Leval L; Jeon YK
Virchows Arch; 2014 Dec; 465(6):731-6. PubMed ID: 25027578
[TBL] [Abstract] [Full Text] [Related]
9. Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades.
Ochi N; Hotta K; Takigawa N; Oze I; Fujiwara Y; Ichihara E; Hisamoto A; Tabata M; Tanimoto M; Kiura K
PLoS One; 2012; 7(8):e42798. PubMed ID: 22880112
[TBL] [Abstract] [Full Text] [Related]
10. Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancer.
Minami-Shimmyo Y; Ohe Y; Yamamoto S; Sumi M; Nokihara H; Horinouchi H; Yamamoto N; Sekine I; Kubota K; Tamura T
J Thorac Oncol; 2012 Jan; 7(1):177-82. PubMed ID: 22134071
[TBL] [Abstract] [Full Text] [Related]
11. Time trend in treatment-related deaths of patients with advanced non-small-cell lung cancer enrolled into phase III trials of systemic treatment.
Fujiwara Y; Hotta K; Di Maio M; Kiura K; Takigawa N; Tabata M; Tanimoto M
Ann Oncol; 2011 Feb; 22(2):376-82. PubMed ID: 20699278
[TBL] [Abstract] [Full Text] [Related]
12. Molecular characterization of a novel chromosomal translocation t(12;14)(q23;q11.2) in T-lymphoblastic lymphoma between the T-cell receptor delta-deleting elements (trdREC and TRAJ61) and the hypothetical gene C12orf42.
Przybylski GK; Dittmann K; Grabarczyk P; Dölken G; Gesk S; Harder L; Landmann E; Siebert R; Schmidt CA
Eur J Haematol; 2010 Nov; 85(5):452-6. PubMed ID: 20659153
[TBL] [Abstract] [Full Text] [Related]
13. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
Song CH; Pyo H; Moon SH; Kim TH; Kim DW; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):651-8. PubMed ID: 20207499
[TBL] [Abstract] [Full Text] [Related]
14. Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer.
Ohe Y; Yamamoto S; Suzuki K; Hojo F; Kakinuma R; Matsumoto T; Ohmatsu H; Nishiwaki Y
Eur J Cancer; 2001 Jan; 37(1):54-63. PubMed ID: 11165130
[TBL] [Abstract] [Full Text] [Related]
15. Detection of the circulating lung cancer marker LCAP with a new monoclonal antibody trd-L1.
Tsuji K; Uwano T; Yoshida Y; Kikuchi K; Okamoto T; Yamamoto S; Ichiki M; Hayashi I; Ohno T; Kufe DW
Int J Biol Markers; 1997; 12(2):49-54. PubMed ID: 9342632
[TBL] [Abstract] [Full Text] [Related]
